Among the concentrations of MSI-1, 2 mg/kg dose of MSI-1 exerted weak antitumor activity but significantly inhibited the activation of the SREBP-1 pathway, Warburg effect, and EMT process of NCI-H226 cells in subcutaneous tumor tissues (Figure 6). Here, SREBF1 is linked to neoplasm.